DecisionPoint Financial »

Crispr Therapeutics shares owned by DecisionPoint Financial

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by DecisionPoint Financial from 13F filings

Historical chart of DecisionPoint Financial investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by DecisionPoint Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by DecisionPoint Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $129k 2.8k 46.98
2024-06-30 $158k 2.8k 57.29
2024-03-31 $148k 2.8k 53.91
2023-12-31 $175k 2.8k 62.60
2023-09-30 $2.2k 48 45.40